These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38640292)

  • 1. Giant retinal pigment epithelial tear following photodynamic therapy for the bullous variant of central serous chorioretinopathy: A case report.
    Kimura E; Miura M
    Medicine (Baltimore); 2024 Apr; 103(16):e37855. PubMed ID: 38640292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral retinal pigment epithelial tears in acute central serous chorioretinopathy without bullous retinal detachment: A case report.
    Lee WH; Kim BJ; Han YS
    Medicine (Baltimore); 2021 Oct; 100(39):e27391. PubMed ID: 34596164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleral thinning surgery for bullous retinal detachment with retinal pigment epithelial tear in central serous chorioretinopathy: a case report.
    Maggio E; Mete M; Maraone G; Arena F; Pertile G
    BMC Ophthalmol; 2020 Apr; 20(1):133. PubMed ID: 32252699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
    Arif F; Pryds A; Larsen M
    Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
    Kim SW; Oh J; Oh IK; Huh K
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
    Goto S; Gomi F; Ueno C; Nishida K
    Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report.
    Liu Y; Wang X; Zhu M; Xu G; Li L
    BMC Ophthalmol; 2019 Mar; 19(1):68. PubMed ID: 30849939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for steroid-associated central serous chorioretinopathy.
    Lee TG; Kim JE
    Br J Ophthalmol; 2011 Apr; 95(4):518-23. PubMed ID: 20679080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
    Zhang Z; Bao X; Wu Z; Zhang J
    Medicine (Baltimore); 2021 Feb; 100(7):e24790. PubMed ID: 33607835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for variant central serous chorioretinopathy: efficacy and side effects.
    Gupta B; Mohamed MD
    Ophthalmologica; 2011; 225(4):207-10. PubMed ID: 21325872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
    Putnam CM; Vang SS
    Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy.
    Lee PY; Kim KS; Lee WK
    Jpn J Ophthalmol; 2009 Jan; 53(1):52-56. PubMed ID: 19184311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Son BK; Kim K; Kim ES; Yu SY
    Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.
    Balaratnasingam C; Freund KB; Tan AM; Mrejen S; Hunyor AP; Keegan DJ; Dansingani KK; Dayani PN; Barbazetto IA; Sarraf D; Jampol LM; Yannuzzi LA
    Ophthalmology; 2016 Jul; 123(7):1541-52. PubMed ID: 27084564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.
    Gao T; Qu J; Xiao J; Hu J; Zhao M
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1429-1439. PubMed ID: 29869216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.